Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on

Biochemical Pharmacology

Volumn 81, Issue 3, 2011, Pages 337-344

  Costa, Lucio G ^a,b   Giordano, Gennaro ^a   Furlong, Clement E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

Author keywords

Alcohol; Anti diabetic drugs; Antioxidants; Hypolipemic drugs; Paraoxonase 1; Polyphenols; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; AMPICILLIN; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; ATORVASTATIN; ATROPINE; BEZAFIBRATE; CIPROFIBRATE; CIPROFLOXACIN; CLINDAMYCIN SULFATE; CYCLOPHOSPHAMIDE; EPLERENONE; ERYTHROPOIETIN BETA; EZETIMIBE; FENOFIBRATE; GEMFIBROZIL; GLIBENCLAMIDE; GLIMEPIRIDE; ORGANOPHOSPHATE INSECTICIDE; POLYPHENOL DERIVATIVE; PROBUCOL; RECOMBINANT ERYTHROPOIETIN; RIFAMYCIN; ROSIGLITAZONE; SIMVASTATIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE TOXICITY; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIET; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; GENETIC POLYMORPHISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIFESTYLE; LIFESTYLE MODIFICATION; LIPID OXIDATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 78650714512     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.11.008     Document Type: Note

References (100)

1. P.N. Durrington, B. Mackness, and M.I. Mackness The hunt for nutritional and pharmacological modulators of paraoxonase Arterioscler Thromb Vasc Biol 22 2002 1248 1250
2. D.J. Draganov, J.F. Teiber, A. Speelman, Y. Osawa, R. Sunahara, and B.N. La Du Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrates specificities J Lipid Res 46 2005 1239 1247
3. E.A. Ozer, A. Pezzulo, D.M. Shih, C. Chun, C.E. Furlong, and A.J. Lusis Human and murine paraoxonase 1 are host modulators of pseudomonas aeruginosa quorum-sensing FEMS Microbiol Lett 253 2005 29 37
4. L.G. Costa, T.B. Cole, G.P. Jarvik, and C.E. Furlong Functional genomics of the paraoxonase (PON1) polymorphisms: effect on pesticide sensitivity, cardiovascular disease, and drug metabolism Annu Rev Med 54 2003 371 392
5. C.J. Ng, D.M. Shih, S.Y. Hama, N. Villa, M. Navab, and S.T. Reddy The paraoxonase gene family and atherosclerosis Free Radic Biol Med 38 2005 153 163
6. C.E. Furlong, L.G. Costa, C. Hassett, R.J. Richter, J.A. Sundstrom, and D.A. Adler Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification Chem Biol Interact 87 1993 35 48
7. V.H. Brophy, G.P. Jarvik, and C.E. Furlong PON1 polymorphisms L.G. Costa, C.E. Furlong, Paraoxonase (PON1) in health and disease: basic and clinical aspects 2002 Kluwer Academic Publishing Boston 53 77
8. S. Billecke, D. Draganov, R. Counsell, P. Stetson, C. Watson, and C. Hsu Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters Drug Metab Dispos 28 2000 1335 1342
9. B. Mackness, P.N. Durrington, and M.I. Mackness Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation Lancet 353 1999 468 469
10. R.J. Richter, and C.E. Furlong Determination of paraoxonase (PON1) status requires more than genotyping Pharmacogenetics 9 1999 745 753
11. R.J. Richter, G.P. Jarvik, and C.E. Furlong Determination of paraoxonase 1 (PON1) status without the use of toxic organophosphate substrates Circ Cardiovasc Genet 1 2008 147 152
12. T.B. Cole, J. Walter, D.M. Shih, A.D. Tward, A.J. Lusis, and C. Timchalk Toxicity of chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism Pharmacogenet Genomics 15 2005 589 598
13. L.G. Costa, A. Vitalone, T.B. Cole, and C.E. Furlong Modulation of paraoxonase (PON1) activity Biochem Pharmacol 69 2005 541 550
14. J. Camps, J. Marsillach, and J. Joven The paraoxonases: role in human diseases and methodological difficulties in measurement Crit Rev Clin Lab Sci 46 2009 83 106
15. 55 genotype Arterioscler Thomb Vasc Biol 20 2000 2441 2447
16. J. Camps, J. Marsillach, and J. Joven Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity Mini Rev Med Chem 9 2009 911 920
17. S. Deakin, I. Leviev, S. Guernier, and R.W. James Statin modulates expression of the PON1 gene and increases serum paraoxonase. A role for sterol regulatory element-binding protein-2 Arterioscler Thromb Vasc Biol 23 2003 2083 2089
18. H.Z. Mirdamadi, F. Sztanek, Z. Derdak, I. Seres, M. Harangi, and G. Paragh The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters Br J Clin Pharmacol 66 2008 366 373
19. M. Harangi, H.Z. Mirdamadi, I. Seres, F. Sztanek, M. Molnar, and A. Kassai Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity Transl Res 153 2009 190 198
20. A. Kassai, L. Illyes, H.Z. Mirdamadi, I. Seres, T. Kalmar, and M. Audikovszky The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase Clin Biochem 40 2007 1 5
21. R.P.F. Dullaart, R. de Vries, H.A.M. Voorbij, W.J. Sluiter, and A. van Tol Serum paraoxonase-1 activity is unaffected by short term administration of simvastin, bezafibrate, and their combination in type 2 diabetes mellitus Eur J Clin Invest 39 2009 200 203
22. C. Gouedard, N. Koum-Besson, R. Barouki, and Y. Morel Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofibrate and statins Mol Pharmacol 63 2003 945 956
23. M. Aviram, M. Rosenblat, C.L. Bisgaier, and R.S. Newton Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation Atherosclerosis 138 1998 271 280
24. K. Ota, T. Suehiro, K. Arii, Y. Ikeda, Y. Kumon, and F. Osaki Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene Metab Clin Exp 54 2005 142 150
25. S. Deakin, S. Guernier, and R.W. James Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin Pharmacogenet Genomics 17 2007 451 457
26. M.A. Sardo, S. Campo, M. Bonaiuto, A. Bonaiuto, C. Saitta, and G. Trimarchi Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55 M polymorphisms in hypercholesterolemic patients Curr Med Res Opin 21 2005 777 784
27. K. Arii, T. Suehiro, K. Ota, Y. Ikeda, Y. Kumon, and F. Osaki Pivastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells Atherosclerosis 202 2009 439 445
28. S. Ahmad, J.J. Carter, and J.E. Scott A homogenous cell-based assay for measurement of endogenous paraoxonase activity Anal Biochem 400 2010 1 9
29. G. Paragh, I. Seres, M. Harangi, A. Erdei, M. Audikovszky, and L. Debreczeni Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome Br J Clin Pharmacol 61 2006 694 701
30. J. Turay, V. Grniakova, and J. Valka Changes in paraoxonase and apolipoprotein A-I, B, C-III and E in subjects with combined familiar hyperlipoproteinemia treated with ciprofibrate Drugs Exp Clin Res 26 2000 83 88
31. P.N. Durrington, M.I. Mackness, D. Bhatnagar, K. Julier, H. Prais, and S. Arrol Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia Atherosclerosis 138 1998 217 225
32. M.C. Blatter-Garin, B. Kalix, S. De Pree, and R.W. James Aspirin use is associated with higher serum concentrations of the antioxidant enzyme, paraoxonase-1 Diabetologia 46 2003 593 594
33. 10 and other oxidative stress markers in human volunteers Clin Biochem 43 2010 287 290
34. P. Jaichander, K. Selvarajan, M. Garelnabi, and S. Parthasarathy Induction of paraoxonase 1 and apolipoprotein A-1 gene expression by aspirin J Lipid Res 49 2008 2142 2148
35. N. Santanam, and S. Parthasarathy Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis Atherosclerosis 191 2007 272 275
36. S.C. Hong, S.P. Zhao, and Z.H. Wu Probucol up-regulates paraoxonase 1 expression in hepatocytes of hypercholesterolemic rabbits J Cardiovasc Pharmacol 47 2006 77 81
37. N. Turfaner, H. Uzun, H. Balci, M.A. Ercan, Y.H. Karter, and M. Caner Ezetimibe therapy and its influence on oxidative stress and fibrinolytic activity South Med J 103 2010 428 433
38. J. van Wijk, B. Coll, M. Castro Cabezas, E. Koning, J. Camps, and T. Rabelink Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients Clin Exp Pharmacol Physiol 33 2006 1134 1137
39. E. Carreon-Torres, K. Randon-Sauer, M. Monter-Garrido, P. Toledo-Ibelles, R. Gamboa, and M. Menjivar Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rate Clin Chim Acta 401 2009 37 41
40. Z. Ackerman, M. Oron-Herman, O. Pappo, E. Peleg, R. Safadi, and H. Shmilowitz-Weiss Hepatic effects of rosiglitazone in rats with the metabolic syndrome Basic Clin Pharmacol Toxicol 107 2010 663 668
41. C. Noll, S. Messaoudi, P. Milliez, J.L. Samule, C. Delcayre, and N. Janel Eplerone administration has beneficial effect on hepatic paraoxonase 1 in diabetic mice Atherosclerosis 208 2010 26 27
42. G. Wojcicka, A. Jamroz-Wisniewska, A. Marciniak, E. Lowicka, and J. Beltowski The differentiating effect of glimepiride and glibenclamide on paraoxonase-1 and platelet-activating factor acetylohydrolase Life Sci. 87 2010 126 132
43. S. Sinan, F. Kockar, N. Gencer, H. Yildirim, and O. Arslan Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo Biol Pharm Bull 29 2006 1559 1563
44. P. Abraham, and E. Sugumar Enhanced PON1 activity in the kidneys of cyclophosphamide treated rats may play a protective role as an antioxidant against cyclophosphamide induced oxidative stress Arch Toxicol 82 2008 237 238
45. S. Kiranoglu, S. Sinan, N. Gencer, F. Kockar, and O. Arslan In vivo effects of oral contraceptives on paraoxonase, catalase and carbonic anydrase enzyme activities on mouse Biol Pharm Bull 30 2007 1048 1051
46. I.V. Fenkci, M. Serteser, S. Fenkci, and A.M. Akyol Effects of intranasal estradiol treatment on serum paraoxonase and lipids in healthy, postmenopausal women Gynecol Obstet Invest 61 2006 203 207
47. W.H.F. Sutherland, P.J. Manning, S.A. de Jong, A.R. Allum, S.D. Jones, and S.M. Williams Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women Metabolism 50 2001 319 324
48. J. Marsillach, A. Martinez-Vea, L. Marcas, B. Mackness, M. Mackness, and N. Ferre' Administration of exogenous erythropoietin β affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anemia Clin Exp Pharmacol Physiol 34 2007 347 349
49. A. Ghorbanihaghjo, H. Argani, M. Rahbaninoubar, and N. Rashtchizadeh Effect of nandrolone decanonate on paraoxonase activity in hemodialysis patients Clin Biochem 38 2005 1076 1080
50. A.O. Barim, S. Aydin, R. Colak, E. Dag, O. Deniz, and I. Sahin Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment Clin Biochem 42 2009 1076 1081
51. J. Beltowski, G. Wojcicka, and H. Jakubowski Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat J Endocrinol 204 2010 191 198
52. D.M. Shih, H.R. Kast-Woelbern, J. Wong, Y.R. Xia, P.A. Edwards, and A.J. Lusis A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids J Lipid Res 47 2006 384 392
53. S.D. Nguyen, and D.E. Sok Oxidative inactivation of paraoxonase 1 an antioxidant protein and its effect on antioxidant action Free Radic Res 37 2003 77 83
54. G.P. Jarvik, N.T. Tsai, L.A. McKinstry, R. Wani, V.H. Brophy, and R.J. Richter Vitamin C and E intake is associated with increased paraoxonase activity Arterioscler Thromb Vasc Biol 22 2002 1329 1333
55. M.F. Gursu, M. Onderci, F. Gulcu, and K. Sahin Effects of vitamin C and folic acid supplementation on serum paraoxonase activity and metabolites induced by heat stress in vivo Nutr Res 24 2004 157 164
56. J.P. Kunes, K.S. Cordero-Koning, L.H. Lee, and S.M. Lynch Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma Nutr Res 29 2009 114 122
57. E. Sarandol, S. Tas, M. Dirican, and Z. Serdar Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation Cell Biochem Funct 23 2005 1 8
58. S.M. Jeon, Y.B. Park, O.S. Kwon, T.L. Huh, W.H. Lee, and K.M. Do Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: comparison with probucol J Biochem Mol Toxicol 19 2005 336 346
59. S. Tsakaris, G.A. Karika, T. Parthimos, T. Taskaris, C. Akogiannis, and K.H. Schulpis Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals Eur J Clin Nutr 63 2009 215 221
60. E. Sarandol, M. Dirican, N. Ocak, Z. Serdar, F. Sonmezisik, and K. Dilek The effects of vitamin e-coated dialysis membranes on serum paraoxonase activity in hemodialysis patients J Nephrol 23 2010 431 437
61. P. Kleemola, R. Freese, M. Jauhiainen, R. Pahlman, G. Alfthan, and M. Mutanen Dietary determinants of serum paraoxonase activity in healthy humans Atherosclerosis 160 2002 425 432
62. C. Boesch-Saadatmandi, J. Niering, A.M. Minihane, I. Wiswedel, A. Gardeman, and S. Wolffram Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice Atherosclerosis 211 2010 110 113
63. C. Noll, J. Hamelet, E. Matulewicz, J.L. Paul, J.M. Delabar, and N. Janel Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice J Nutr Biochem 20 2009 586 596
64. M. Gong, M. Garige, R. Varatharajalu, P. Marmillot, C. Gottipatti, and L.C. Leckey Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation Biochem Biophys Res Commun 379 2009 1001 1004
65. C. Boesch-Saadatmandi, S. Egert, C. Schrader, X. Coumoul, R. Barouki, and M.J. Muller Effect of quercetin on paraoxonase 1 activity - studies in cultured cells, mice and humans J Physiol Pharmacol 61 2010 99 105
66. -/- mice Alcohol Clin Exp Res 34 2010 1535 1542
67. C. Gouedard, R. Barouki, and Y. Morel Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism Mol Cell Biol 2004 5209 5222
68. M. Garige, M. Gong, R. Varatharajalu, and M.R. Lakshman Quercetin up-regulates paraoxonase 1 gene expression via sterol regulatory element binding protein 2 that translocates from the endoplasmic reticulum to the nucleus where it specifically interacts with sterol responsive element-like sequences in paraoxonase 1 promoter in HuH7 liver cells Metab Clin Exp 59 2010 1372 1378
69. S.P. Hsu, M.S. Wu, C.C. Yang, K.C. Huang, S.Y. Liou, and S.M. Hsu Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines Am J Clin Nutr 86 2007 1539 1547
70. S. Tas, E. Sarandol, S. Ziyanok, K. Aslan, and M. Dirican Effects of green tea on serum paraoxonase/arylesterase activities in streptozotocin-induced diabetic rats Nutr Res 25 2005 1061 1074
71. C. Gouedard, R. Barouki, and Y. Morel Induction of the paraoxonase-1 gene expression by resveratrol Arterioscler Thromb Vasc Biol 24 2004 2378 2383
72. A. Kiyici, N. Okudan, H. Gokbel, and M. Belviranli The effect of grape seed extract on serum paraoxonase activities in streptozotocin-induced diabetic rats J Med Food 13 2010 1 4
73. X. Wu, J. Kang, C. Xie, R. Burris, M.E. Ferguson, and T.M. Badger Dietary blueberries attenuate atherosclerosis in apolipoprotein E-deficient mice by upregulating antioxidant enzyme expression J Nutr 140 2010 1628 1632
74. ® decreases plasma osteopontin and improves markers of oxidative stress in muscular dystrophy Mdx mice J Diet Suppl 7 2010 159 178
75. M. Kaplan, T. Hayek, A. Raz, R. Coleman, L. Dornfeld, and J. Vaya Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis J Nutr 131 2001 2082 2089
76. W. Rock, M. Rosenblat, R. Miller-Lotan, A.P. Levy, M. Elias, and M. Aviram Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities J Agric Food Chem 56 2008 8704 8713
77. 0) mice and in vitro in cultured macrophages and lipoproteins J Agric Food Chem 56 2008 1148 1157
78. B. Fuhrman, N. Volkova, and M. Aviram Pomegranate juice polyphenols increase recombinant paraoxonase 1 binding to high-density lipoproteins: studies in vitro and in diabetic patients Nutrition 26 2010 359 366
79. J. Khateeb, A. Gatman, A.J. Kreitenberg, M. Aviram, and B. Fuhrman Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-γ pathway Atherosclerosis 208 2010 119 125
80. W. Rock, M. Rosenblat, H. Borochov-Neori, N. Volkova, S. Judeistein, and M. Elias Effects of date (Phoenix dactylifera L., Medjool or Hallawi variety) consumption by healthy subjects on serum glucose and lipid levels and on serum oxidative status: a pilot study J Agric Food Chem 57 2009 8010 8017
81. M. Dirican, S. Tas, and E. Sarandol High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism Clin Exp Pharmacol Physiol 34 2007 833 837
82. M. Oliveira de Souza, M. Silva, M.E. Silva, R. de Paula Oliveira, and M.L. Pedrosa Diet supplementation with acai (Euterpe oleracea Mart.) pulp improves biomarkers of oxidative stress and the serum lipid profile in rats Nutrition 26 2010 804 810
83. Ustundag, I.H. Bahcecioglu, K. Sahin, S. Duzgun, S. Koca, and F. Gulcu Protective role of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model Dig Dis Sci 52 2007 2006 2014
84. A.J. Wallace, W.H.F. Sutherland, J.I. Mann, and S.M. Williams The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes Eur J Clin Nutr 55 2001 951 958
85. M. Tomas, M. Senti, R. Elousa, J. Vila, J. Sala, and R. Masia Interaction between Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high density lipoprotein cholesterol and paraoxonase activity Eur J Pharmacol 432 2001 121 128
86. S. Blum, M. Aviram, A. Be-AMotz, and Y. Levy The effect of a Mediteranean meal on postprandial carotenoids, paraoxonase activity and C-reactive protein levels Ann Nutr Metab 50 2006 20 24
87. L. Calabresi, B. Villa, M. Canavesi, C.R. Sirtori, R.W. James, and F. Bernini An ω-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia Metabolism 53 2004 153 158
88. S.D. Nguyen, and D.E. Sok Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization Biochem J 375 2003 275 285
89. S.D. Nguyen, and D.E. Sok Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids J Lipid Res 45 2004 2211 2220
90. M.S. van de Gaag, A. van Tol, L.M. Scheek, R.W. James, R. Urgert, and G. Schaafsma Daily moderate alcohol consumption increases serum paraoxoanse activity; a diet-controlled, randomized intervention study in middle-aged men Atherosclerosis 147 1999 405 410
91. A. Sierksma, M. van der Gaag, A. van Tol, R.W. James, and H.F.J. Hendriks Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers Alcohol Clin Exp Res 26 2002 1430 1435
92. E. Sarandol, Z. Serdar, M. Dirican, and O. Safak Effect of red wine consumption on serum paraoxonase/arylesterase activities and on lipoprotein oxidizability in healthy men J Nutr Biochem 14 2003 507 512
93. M.N. Rao, P. Marmillot, M. Gong, D.A. Palmer, L.B. Seef, and D.B. Strader Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans Metabolism 10 2003 1287 1294
94. F. Osaki, Y. Ikeda, T. Suehiro, K. Ota, S. Tsuzura, and K. Arii Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells Atherosclerosis 176 2004 279 287
95. Y. Ikeda, T. Suehiro, K. Arii, Kumon, and K. Hashimoto High glucose induces transactivation of the human paraoxonase gene in hepatocytes Metab Clin Exp 57 2008 1725 1732
96. J. Marsillach, N. Ferre, M.C. Vila, A. Lligona, B. Mackness, and M. Mackness Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease Clin Biochem 40 2007 645 650
97. R. Varatharajalu, M. Garige, L.C. Leckey, M. Gong, and M.R. Lakshman Betaine protects chronic alcohol and w-3 PUFA-mediated down-regulations of PON1 gene, serum PON1 and homocysteine thiolactonase activities with restoration of liver GSH Alcohol Clin Exp Res 34 2010 424 431
98. R.C. Stevens, S.M. Suzuki, T.B. Cole, S.S. Park, R.J. Richter, and C.E. Furlong Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning Proc Natl Acad Sci USA 105 2008 12780 12784
99. P.J. Guns, T. Van Assche, W. Verreth, P. Fransen, B. Mackness, and M. Mackness Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis Br J Pharmacol 153 2008 508 516
100. C. Zhang, W. Peng, M. Wang, J. Zhu, Y. Zang, and W. Shi Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice Gene Ther 17 2010 626 633